Quantum Corporation (QMCO) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Entered into a definitive agreement to restructure outstanding term debt, exchanging ~$52M of debt for senior secured convertible notes with a three-year maturity, subject to shareholder approval.
Amended the term loan credit agreement to remove leverage and minimum liquidity covenants, and allow retention of up to $15M in equity proceeds for working capital.
Issued a warrant to purchase 2,653,308 shares (19.9% of outstanding shares) to Dialectic as consideration for forbearance and amendments.
The transaction is positioned as a key milestone toward eliminating outstanding debt and increasing financial flexibility.
Voting matters and shareholder proposals
Stockholder approval is required for the debt exchange, any additional convertible note issuances, and the issuance of shares upon exercise of the warrant in excess of 19.99% of outstanding shares.
The board recommends shareholders vote in favor of the debt exchange and related share issuances.
The board may change its recommendation or terminate the agreement in favor of a superior proposal, subject to fiduciary duties.
Board of directors and corporate governance
A special committee of independent directors evaluated and approved the transaction, determining it to be fair and in the best interests of shareholders.
The board, with interested directors abstaining, approved the transaction and recommended it to shareholders.
Recent changes to the board and executive team are highlighted as part of a broader transformation.
Latest events from Quantum Corporation
- Debt converted to equity via notes, enabling resale of up to 18.2M shares by a major lender.QMCO
Registration Filing19 Feb 2026 - Q3 revenue and EBITDA exceeded guidance, but supply chain and going concern risks persist.QMCO
Q3 202617 Feb 2026 - Revenue fell 26% as net loss widened, but margin and subscription ARR improved sharply.QMCO
Q4 20243 Feb 2026 - Revenue fell 23% year-over-year, net loss widened, and subscription ARR rose 29%.QMCO
Q1 20252 Feb 2026 - Q2 revenue fell 7% YoY; margin and subscription ARR rose, but net loss widened.QMCO
Q2 202514 Jan 2026 - Revenue fell 11% as cost actions and new capital target a turnaround amid liquidity risks.QMCO
Q1 202627 Dec 2025 - Up to $200 million in equity may be raised over three years, with proceeds for working capital and debt repayment.QMCO
Registration Filing16 Dec 2025 - Revenue and margin rose, but a warrant revaluation led to a steep net loss and liquidity risks.QMCO
Q3 20253 Dec 2025 - Shareholders must vote by Dec 15, 11:59 PM ET, for the Dec 16 Annual Meeting.QMCO
Proxy Filing2 Dec 2025